We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVLR
1701
DELISTED
Avalara, Inc.
AVLR
$5.2M ﹤0.01%
77,309
-63,463
-45% -$5.13M
KBWB icon
1702
Invesco KBW Bank ETF
KBWB
$6.84B
$5.19M ﹤0.01%
100,815
-77,677
-44% -$3.89M
FEZ icon
1703
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.42B
$5.19M ﹤0.01%
137,503
+67,855
+97% +$2.53M
DNKN
1704
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$5.19M ﹤0.01%
65,336
-11,574
-15% -$940K
RGEN icon
1705
Repligen
RGEN
$7.96B
$5.18M ﹤0.01%
67,603
+43,574
+181% +$3.81M
TRP icon
1706
CALL
TC Energy
TRP
$70.2B
$5.18M ﹤0.01%
+100,000
New +$4.99M
FXH icon
1707
First Trust Health Care AlphaDEX Fund
FXH
$1.04B
$5.17M ﹤0.01%
69,866
+6,997
+11% +$534K
RRD
1708
DELISTED
RR Donnelley & Sons Co.
RRD
$5.17M ﹤0.01%
1,371,301
+153,452
+13% +$365K
ELV icon
1709
PUT
Elevance Health
ELV
$81.5B
$5.16M ﹤0.01%
21,500
+6,500
+43% +$1.78M
CERN
1710
PUT
DELISTED
Cerner Corp
CERN
$5.11M ﹤0.01%
75,000
PXD
1711
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
$5.11M ﹤0.01%
40,600
-252,600
-86% -$33.4M
BKR icon
1712
PUT
Baker Hughes
BKR
$60B
$5.1M ﹤0.01%
220,000
+89,600
+69% +$2.1M
NBR icon
1713
Nabors Industries
NBR
$1.27B
$5.1M ﹤0.01%
54,520
+12,146
+29% +$1.37M
ITRI icon
1714
Itron
ITRI
$4.36B
$5.09M ﹤0.01%
68,849
-17,668
-20% -$1.19M
FCN icon
1715
FTI Consulting
FCN
$4.4B
$5.08M ﹤0.01%
47,969
+3,001
+7% +$306K
KW
1716
DELISTED
Kennedy-Wilson Holdings
KW
$5.08M ﹤0.01%
231,952
+16,367
+8% +$349K
CLDR
1717
DELISTED
Cloudera, Inc.
CLDR
$5.08M ﹤0.01%
573,546
-255,299
-31% -$1.77M
RMBS icon
1718
Rambus
RMBS
$9.87B
$5.08M ﹤0.01%
386,750
+45,652
+13% +$572K
AGO icon
1719
Assured Guaranty
AGO
$3.66B
$5.06M ﹤0.01%
113,872
+6,136
+6% +$270K
DOX icon
1720
Amdocs
DOX
$5.92B
$5.05M ﹤0.01%
76,340
-11,708
-13% -$752K
AQUA
1721
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$5.05M ﹤0.01%
296,488
+3,352
+1% +$50.4K
CW icon
1722
Curtiss-Wright
CW
$26.7B
$5.03M ﹤0.01%
38,868
-18,888
-33% -$2.38M
DK icon
1723
Delek US
DK
$4.16B
$5.03M ﹤0.01%
138,462
-17,528
-11% -$645K
BERY
1724
PUT
DELISTED
Berry Global Group, Inc.
BERY
$5.02M ﹤0.01%
+139,174
New +$5.69M
WWD icon
1725
Woodward
WWD
$21.3B
$5.02M ﹤0.01%
46,514
-75,316
-62% -$8.28M

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.